Valuation: Southern Acids (M)

Market Cap 415M 102M 88.93M 82.09M 76.57M 144M 9.61B 147M 985M 382M 4.74B 382M 373M 16.51B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.76M 10.29M 9.5M 8.86M 16.7M 1.11B 17M 114M 44.25M 549M 44.19M 43.2M 1.91B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
1 month-1.26%
3 months+3.63%
6 months-1.26%
Current year-1.26%
1 month 3.1
Extreme 3.1
3.28
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 14/07/2015
Director of Finance/CFO 58 30/09/2013
Chief Tech/Sci/R&D Officer 38 15/07/2014
Director TitleAgeSince
Director/Board Member 66 09/08/2005
Director/Board Member 59 19/03/2012
Chairman 79 14/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-5.42%-8.99% 106M
-2.11%-0.86%-3.79%+291.09% 5.06B
-0.42%+1.88%+14.63%+94.75% 1.66B
-3.41%-1.98%+31.13%+57.46% 734M
-4.05%-8.97%+45.45%+0.53% 653M
+4.35%+2.70%+34.23%+105.40% 509M
-2.71%-8.38%-25.59%-33.82% 487M
-1.35%-11.35%+63.89%+1.73% 426M
+0.71%-0.59%+3.08%-0.65% 362M
+0.53%+0.85%+26.59%+62.49% 305M
Average -0.85%-1.86%+18.42%+57.00% 1.03B
Weighted average by Cap. -1.53%-0.80%+9.56%+167.82%

Financials

2024 2025
Net sales 920M 225M 197M 182M 170M 320M 21.3B 326M 2.18B 848M 10.51B 847M 828M 36.63B 1.11B 271M 237M 219M 204M 385M 25.61B 391M 2.62B 1.02B 12.64B 1.02B 995M 44.02B
Net income 13.63M 3.34M 2.92M 2.7M 2.52M 4.74M 316M 4.83M 32.36M 12.56M 156M 12.54M 12.26M 543M 36.7M 8.99M 7.87M 7.26M 6.77M 12.76M 850M 12.99M 87.1M 33.81M 419M 33.76M 33.01M 1.46B
Net Debt -372M -91.14M -79.77M -73.64M -68.69M -129M -8.62B -132M -883M -343M -4.25B -342M -335M -14.81B -367M -89.83M -78.63M -72.59M -67.71M -128M -8.49B -130M -871M -338M -4.19B -338M -330M -14.6B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. 5134 Stock